Inhibition of neutrophil migration in vitro by win 55,212-2

被引：0
|
作者：
Nilsson, O [1 ]
Jacobsson, SO [1 ]
机构：
[1] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden
来源：
JOURNAL OF NEUROCHEMISTRY | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [21] The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
    C Morell
    A Bort
    D Vara
    A Ramos-Torres
    N Rodríguez-Henche
    I Díaz-Laviada
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 248 - 257
  • [22] Behavioral Effects of Chronic WIN 55,212-2 Administration During Adolescence and Adulthood in Mice
    Johnson, Katelyn R.
    Boomhower, Steven R.
    Newland, M. Christopher
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 27 (04) : 348 - 358
  • [23] The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines
    Mueller, Leonie
    Radtke, Arlo
    Decker, Jennifer
    Koch, Michael
    Belge, Gazanfer
    ANTICANCER RESEARCH, 2017, 37 (11) : 6341 - 6345
  • [24] CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2
    Nemeth, Beata
    Ledent, Catherine
    Freund, Tamas F.
    Hajos, Norbert
    NEUROPHARMACOLOGY, 2008, 54 (01) : 51 - 57
  • [25] The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
    Morell, C.
    Bort, A.
    Vara, D.
    Ramos-Torres, A.
    Rodriguez-Henche, N.
    Diaz-Laviada, I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) : 248 - 257
  • [26] A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
    Pascual, D
    Goicoechea, C
    Suardíaz, M
    Martín, MI
    PAIN, 2005, 118 (1-2) : 23 - 34
  • [27] The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats
    Schneider, M
    Koch, M
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (01): : 29 - 37
  • [28] Effects of cannabinoid WIN 55,212-2 on caffeine contractures in frog slow skeletal muscle
    Velasco, R
    Del Toro, M
    Lozoya, R
    Trujillo, X
    Vásquez, C
    Huerta, M
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 397A - 398A
  • [29] Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury
    Hama, Aldric
    Sagen, Jacqueline
    EXPERIMENTAL NEUROLOGY, 2007, 204 (01) : 454 - 457
  • [30] Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests
    Burgos, Elisa
    Pascual, David
    Martin, Maria Isabel
    Goicoechea, Carlos
    EUROPEAN JOURNAL OF PAIN, 2010, 14 (01) : 40 - 48
12345